(Q39480157)

12 September 2017

title

Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure (English)

1 reference

12 September 2017

1 reference

1 reference

high-energy radiotherapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525039

18 May 2024

author name string

B. W. Corn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525039

18 May 2024

R. M. Lanciano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525039

18 May 2024

M. Boente

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525039

18 May 2024

W. M. Hunter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525039

18 May 2024

J. Ladazack

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525039

18 May 2024

R. F. Ozols

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525039

18 May 2024

language of work or name

English

0 references

publication date

1 December 1994

1 reference

full work available at URL

12 September 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819941201%2974%3A11%3C2979%3A%3AAID-CNCR2820741114%3E3.0.CO%3B2-B

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525039

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

18 May 2024

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

18 May 2024

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

18 May 2024

1 reference

12 September 2017

volume

74

1 reference

12 September 2017

issue

11

1 reference

12 September 2017

page(s)

2979-2983

1 reference

Hexamethylmelamine chemotherapy for persistent or recurrent epithelial ovarian cancer

12 September 2017

cites work

2

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

Palliative benefit of radiation therapy in advanced ovarian cancer

18 May 2024

5

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

The linear-quadratic formula and progress in fractionated radiotherapy

18 May 2024

6

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

Palliative radiotherapy for ovarian cancer

18 May 2024

9

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of second-line therapy in 105 patients

18 May 2024

10

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin

18 May 2024

11

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease

18 May 2024

12

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

Hexamethylmelamine as second-line therapy in platin-resistant ovarian cancer

18 May 2024

13

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

Hexamethylmelamine in ovarian cancer after failure of cisplatin-based multiple-agent chemotherapy

18 May 2024

14

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

18 May 2024

15

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

Second-line chemotherapy for recurrent carcinoma of the ovary.

18 May 2024

16

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma

18 May 2024

17

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

The management of ovarian-cancer-caused bowel obstruction

18 May 2024

18

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

A new isoeffect curve for change in dose per fraction

18 May 2024

19

1 reference

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2979::AID-CNCR2820741114%3E3.0.CO;2-B

18 May 2024

Identifiers

10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B

1 reference

12 September 2017

1 reference